NeuPath Health Inc. filed its Annual on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.195 CAD | 0.00% | +14.71% | +5.41% |
03-15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
03-15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.41% | 8.05M | |
+17.73% | 83.47B | |
-32.08% | 69.72B | |
-3.24% | 26.37B | |
+4.13% | 17.86B | |
-13.68% | 16.83B | |
+0.75% | 15.7B | |
+74.92% | 13.45B | |
+73.16% | 12.81B | |
-2.02% | 12.44B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt